Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis
Yunfei Zhou(Harbin Medical University), Michael G. Brattain(Nebraska Medical Center)
Cited by 96
Related Papers
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
|Cancer Research|2011|376
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
|Science Translational Medicine|2018|285
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice
|Cell|2024|253
Sumoylation Inhibits Cleavage of Sp1 N-terminal Negative Regulatory Domain and Inhibits Sp1-dependent Transcription
|Journal of Biological Chemistry|2006|86
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status
|Cancer Chemotherapy and Pharmacology|2006|74